Publication:
α-Linolenic and γ-linolenic acids exercise differential antitumor effects on HT-29 human colorectal cancer cells.

dc.contributor.authorGonzalez-Fernandez, Maria Jose
dc.contributor.authorOrtea, Ignacio
dc.contributor.authorGuil-Guerrero, Jose Luis
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderEuropean Social Fund
dc.date.accessioned2023-02-09T09:40:23Z
dc.date.available2023-02-09T09:40:23Z
dc.date.issued2020-06-03
dc.description.abstractα-Linolenic acid (ALA, 18:3n-3) and γ-gamma linolenic acid (GLA, 18:3n-6) are polyunsaturated fatty acids (PUFA) that improve the human health. The present study focused on testing the in vitro antitumor actions of pure ALA and GLA on the HT-29 human colorectal cancer cell line. Cell viability was checked by MTT ((3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test, cell membrane damage by the lactate dehydrogenase assay, apoptosis was tested by both caspase-3 activity trial and transmission electron microscopy images, and protein composition was analyzed by quantitative proteomics analysis. MTT test revealed IC50 values of 230 and 255 μM for ALA and GLA, respectively, at 72 h. After 24 h of incubation, both ALA and GLA induced apoptosis on HT-29 colorectal cancer cells according to the caspase-3 assay and microscopy images. SWATH/MS analysis evidenced that ALA significantly affected the mitochondrial protein import pathway and the citric acid cycle pathway, while GLA did not significantly affect any particular pathway. In summary, both ALA and GLA showed concentration-dependent inhibitory effects on HT-29 cells viability and induced cell death by apoptosis. ALA significantly affected cellular pathways, while GLA does not have specific actions on either pathway. Both n-3 and n-6 C18 PUFA are bioactive food components useful in the colorectal cancer prevention.
dc.description.versionSi
dc.identifier.citationGonzález-Fernández MJ, Ortea I, Guil-Guerrero JL. α-Linolenic and γ-linolenic acids exercise differential antitumor effects on HT-29 human colorectal cancer cells. Toxicol Res (Camb). 2020 Jul 27;9(4):474-483
dc.identifier.doi10.1093/toxres/tfaa046
dc.identifier.issn2045-452X
dc.identifier.pmcPMC7467275
dc.identifier.pmid32905142
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467275/pdf
dc.identifier.unpaywallURLhttps://academic.oup.com/toxres/article-pdf/9/4/474/33707795/tfaa046.pdf
dc.identifier.urihttp://hdl.handle.net/10668/16235
dc.issue.number4
dc.journal.titleToxicology research
dc.journal.titleabbreviationToxicol Res (Camb)
dc.language.isoen
dc.organizationInstituto de Investigación e Innovación en Ciencias Biomédicas
dc.page.number474-483
dc.provenanceRealizada la curación de contenido 19/08/2024
dc.publisherOxford University Press
dc.pubmedtypeJournal Article
dc.relation.projectIDCP19/00164
dc.relation.publisherversionhttps://academic.oup.com/toxres/article/9/4/474/5876106?login=false
dc.rights.accessRightsopen access
dc.subjectHT-29 cells
dc.subjectSWATH-MS
dc.subjectCaspase-3
dc.subjectColorectal cancer
dc.subjectα-linolenic acid
dc.subjectγ-linolenic acid
dc.subject.decsBromuros
dc.subject.decsCaspasa 3
dc.subject.decsCiclo del ácido cítrico
dc.subject.decsCélulas HT29
dc.subject.decsL-lactato deshidrogenasa
dc.subject.decsProteómica
dc.subject.decsSupervivencia celular
dc.subject.decsÁcido alfa-linolénico
dc.subject.meshBromides
dc.subject.meshL-lactate dehydrogenase
dc.subject.meshHT29 cells
dc.subject.meshAlpha-linolenic acid
dc.subject.meshCell survival
dc.subject.meshCaspase 3
dc.subject.meshCitric acid cycle
dc.subject.meshProteomics
dc.titleα-Linolenic and γ-linolenic acids exercise differential antitumor effects on HT-29 human colorectal cancer cells.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format